DNA4Life announced the launch of their Pharmacogenetic Report, a genetic test that can analyze a patient’s DNA to predict their response commonly prescribed medications across therapeutic classes.
The DNA4Life Pharmacogenetic Report evaluates 12 of the most common genes linked to drug metabolism and response; this information is then compared with more than 120 of the most frequently prescribed drugs from multiple therapeutic classes. The online physician-integrated ordering system and requirement that patients share their results with their clinician ensures that patients receive the appropriate medical context and support with this information.
Additional reports are also under development, including those to evaluate wellness, dermatology, and women’s health. The DNA4Life Pharmacogenetic Report retails for $249 and can be ordered from the company website.
For more information visit DNA4Life.com.